Structural analysis of the catalytic domain of Artemis endonuclease/SNM1C reveals distinct structural features
Journal Article
·
· Journal of Biological Chemistry
- Albany Molecular Research Inc., Buffalo, NY (United States)
- Univ. of Southern California Keck School of Medicine, Los Angeles, CA (United States)
- Southern Research, Birmingham, AL (United States)
The endonuclease Artemis is responsible for opening DNA hairpins during V(D)J recombination and for processing a subset of pathological DNA double-strand breaks. Artemis is an attractive target for the development of therapeutics to manage various B cell and T cell tumors, because failure to open DNA hairpins and accumulation of chromosomal breaks may reduce the proliferation and viability of pre-T and pre-B cell derivatives. However, structure-based drug discovery of specific Artemis inhibitors has been hampered by a lack of crystal structures. Here, we report the structure of the catalytic domain of recombinant human Artemis. The catalytic domain displayed a polypeptide fold similar overall to those of other members in the DNA cross-link repair gene SNM1 family and in mRNA 3'-end-processing endonuclease CPSF-73, containing metallo-β-lactamase and β-CASP domains and a cluster of conserved histidine and aspartate residues capable of binding two metal atoms in the catalytic site. As in SNM1A, only one zinc ion was located in the Artemis active site. However, Artemis displayed several unique features. Unlike in other members of this enzyme class, a second zinc ion was present in the β-CASP domain that leads to structural reorientation of the putative DNA-binding surface and extends the substrate-binding pocket to a new pocket, pocket III. Moreover, the substrate-binding surface exhibited a dominant and extensive positive charge distribution compared with that in the structures of SNM1A and SNM1B, presumably because of the structurally distinct DNA substrate of Artemis. The structural features identified here may provide opportunities for designing selective Artemis inhibitors.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- Industrial Macromolecular Crystallography Association; National Cancer Institute (NCI); National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH); USDOE Office of Science (SC)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1763091
- Alternate ID(s):
- OSTI ID: 1764288
OSTI ID: 1765237
- Journal Information:
- Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 35 Vol. 295; ISSN 0021-9258
- Publisher:
- American Society for Biochemistry and Molecular BiologyCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Polyadenylation Factor CPSF-73 is the Pre-mRNA 3'-end-processing Endonuclease
An examination of the metal ion content in the active sites of human endonucleases CPSF73 and INTS11
Restoration of G1 chemo/radioresistance and double-strand-break repair proficiency by wild-type but not endonuclease-deficient Artemis
Journal Article
·
Sat Dec 31 23:00:00 EST 2005
· Nature
·
OSTI ID:930590
An examination of the metal ion content in the active sites of human endonucleases CPSF73 and INTS11
Journal Article
·
Tue Feb 21 19:00:00 EST 2023
· Journal of Biological Chemistry
·
OSTI ID:2423281
Restoration of G1 chemo/radioresistance and double-strand-break repair proficiency by wild-type but not endonuclease-deficient Artemis
Journal Article
·
Thu Apr 28 20:00:00 EDT 2011
· Nucleic Acids Research
·
OSTI ID:1625488